1. Home
  2. Analysis
  3. Zetia
  4. Vidaza

Zetia and Vidaza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 20 people who take Zetia and Vidaza. Common interactions include platelet count decreased among females, and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people who take Zetia and Vidaza have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

20 people who take Zetia and Vidaza together, and have interactions are studied.

What is Zetia?

Zetia has active ingredients of ezetimibe. It is used in high blood cholesterol. Currently, eHealthMe is studying from 48,021 Zetia users.

What is Vidaza?

Vidaza has active ingredients of azacitidine. It is used in myelodysplastic syndrome. Currently, eHealthMe is studying from 12,477 Vidaza users.

Number of Zetia and Vidaza reports submitted per year:

Zetia and Vidaza drug interactions.

Common Zetia and Vidaza drug interactions by gender *:

female:

  1. Platelet count decreased
  2. Anaemia
  3. Pneumonia
  4. Diarrhoea
  5. Injection site pain
  6. Necrotising fasciitis
  7. Pancytopenia
  8. Pyrexia
  9. Sepsis
  10. Febrile neutropenia

male:

  1. Febrile neutropenia
  2. Acute myocardial infarction
  3. Oedema peripheral
  4. Protein urine present
  5. Proteinuria
  6. Visual acuity reduced
  7. Weight decreased
  8. White blood cell count decreased
  9. Ageusia
  10. Cellulitis

Common Zetia and Vidaza drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Febrile neutropenia
  2. Platelet count decreased
  3. Diarrhoea
  4. Injection site pain
  5. Necrotising fasciitis
  6. Pancytopenia
  7. Pyrexia
  8. Sepsis
  9. Haemoglobin decreased
  10. Neutrophil count decreased

Common conditions people have *:

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 25.00%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%
  3. Type 1 Diabetes: 1 person, 5.00%
  4. Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 1 person, 5.00%
  5. Anaemia (lack of blood): 1 person, 5.00%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.00%
  7. Autonomic Neuropathy (malfunction of the autonomic nervous system (ans)): 1 person, 5.00%
  8. Depression: 1 person, 5.00%
  9. Enlarged Prostate: 1 person, 5.00%
  10. Gastric Ph Decreased: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Zetia and Vidaza?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Zetia drug interactions:

Browse interactions between Zetia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vidaza drug interactions:

Browse interactions between Vidaza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe and azacitidine (the active ingredients of Zetia and Vidaza, respectively), and Zetia and Vidaza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Zetia and Vidaza.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.